Enhancer ID: | E_01_0110 |
Species: | human |
Position : | chr1:153659104-153661104 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Antiviral |
Pubmed ID: | 31878072 |
Enhancer experiment: | RT qPCR, Western blot, CO immunoprecipitation, immunofluorescence |
Enhancer experiment description: | Therefore, we present a distinct mechanism by which EV71 antagonizes ILF2-mediated antiviral effects by inhibiting ILF2 expression and promoting ILF2 translocation from the nucleus to the cytoplasm through its 2B protein. |
Target gene : | ILF2 |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | Therefore, we present a distinct mechanism by which EV71 antagonizes ILF2-mediated antiviral effects by inhibiting ILF2 expression and promoting ILF2 translocation from the nucleus to the cytoplasm through its 2B protein. |
TF name : | -- |
TF experiment: | RT-qPCR?Western blot??????????? |
TF experiment description: | Therefore, we present a distinct mechanism by which EV71 antagonizes ILF2-mediated antiviral effects by inhibiting ILF2 expression and promoting ILF2 translocation from the nucleus to the cytoplasm through its 2B protein. |
Enhancer function : | Therefore, we present a distinct mechanism by which EV71 antagonizes ILF2-mediated antiviral effects by inhibiting ILF2 expression and promoting ILF2 translocation from the nucleus to the cytoplasm through its 2B protein. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
Therefore, we present a distinct mechanism by which EV71 antagonizes ILF2-mediated antiviral effects by inhibiting ILF2 expression and promoting ILF2 translocation from the nucleus to the cytoplasm through its 2B protein. |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|